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Bacterial toxins are virulence factors that manipulate host cell functions and take over
the control of vital processes of living organisms to favor microbial infection. Some
toxins directly target innate immune cells, thereby annihilating a major branch of the
host immune response. In this review we will focus on bacterial toxins that act from
the extracellular milieu and hinder the function of macrophages and neutrophils. In
particular, we will concentrate on toxins from Gram-positive and Gram-negative bacteria
that manipulate cell signaling or induce cell death by either imposing direct damage to
the host cells cytoplasmic membrane or enzymatically modifying key eukaryotic targets.
Outcomes regarding pathogen dissemination, host damage and disease progression
will be discussed.
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INTRODUCTION
Macrophages and neutrophils are central mediators of the innate immune system that act at
early stages of bacterial infection and have the ability to clear the pathogen through phagocytosis
and subsequent digestion (Mantovani et al., 2011; Wynn et al., 2013). Besides their overlapping
functional properties, macrophages, and neutrophils also display distinct and specialized features
allowing their concerted and cooperative action against pathogens (Appelberg, 2007; Silva,
2010; Silva and Correia-Neves, 2012). Accordingly to their antimicrobial capacity, toxicity,
and lifespan, macrophages and neutrophils have diﬀerent localizations. Long-lived macrophages
are distributed in tissues throughout the body where they perform local immune surveillance
activities, including recognition, phagocytosis, and rapid signaling of invading pathogens. The
number of resident macrophages in resting tissues is rather low. Upon infection resident
macrophages secrete chemokines, rapidly recruiting monocytes, and quiescent neutrophils from
blood and bone marrow pools to the infectious foci. Monocytes diﬀerentiate to short-lived mature
macrophages and neutrophils are activated to produce powerful antimicrobial molecules and
release proinﬂammatory cytokines and chemokines amplifying the initial chemotactic role of
resident macrophages and sustaining antimicrobial activities (Mantovani et al., 2011; Wynn et al.,
2013).
The outcome of an infection is dictated by the nature of host-pathogen interactions
and greatly depends on the eﬃcacy of phagocytes. When, through the action of virulence
determinants, the pathogen takes the control of the interaction in detriment of the host,
the infection establishes. By the contrary, if the host immune defenses dominate over the
pathogen, the infection is controlled and the pathogen is eliminated. In this scenario, several
human pathogens evolved an arsenal of sophisticated mechanisms to evade host defenses.
In particular, given the central role of macrophages and neutrophils as primary phagocytes,
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several pathogens deploy strategies to either survive or annihilate
phagocytes antimicrobial functions (Flannagan et al., 2009). To
avoid macrophage antimicrobial properties, some intracellular
pathogens interfere with the classical maturation of the
phagosome, blocking fusion with endosomes, and lysosomes
thereby preventing destruction. Others escape the phagosome
to multiply in the cytosol and modulate host gene expression
to limit production of cytokines that would be deleterious for
pathogen progression. Despite the mechanisms of evasion of
neutrophil-killing are yet poorly deﬁned, it is known that some
pathogens survive and multiply inside neutrophils which may
act as Trojan horses for microbial dissemination (Appelberg,
2007). From the extracellular milieu, some pathogens target
macrophage and neutrophils mainly through the secretion of
toxins that: (1) cause irreversible damage leading to phagocyte
death or (2) heavily perturb intracellular signaling pathways,
blocking phagocytosis or modulating inﬂammation (e.g., through
the control of expression of chemokines and cytokines; Lemichez
and Barbieri, 2013).
Toxins are potent molecules produced by a large variety of
bacterial pathogens that target host cells and play key roles in
the host–pathogen dialog. They are major virulence factors often
suﬃcient to determine the outcome of the infection. Indeed,
attesting their importance in pathogenesis, the injection of small
amounts of some puriﬁed toxins can recapitulate many key
symptoms of the disease. Bacterial toxins can be divided in several
groups regarding their nature and mode of action (Lemichez and
Barbieri, 2013). In this review we focus on bacterial exotoxins,
which are secreted by the pathogen and act on the host cells from
the extracellular milieu. Although exotoxins may target diﬀerent
cell types, some speciﬁcally target macrophages and neutrophils
thus taking the control of innate immune response, providing
the pathogen a suitable environment for active proliferation.
Interestingly, while the initial steps of phagocytes intoxication
are speciﬁc for diﬀerent exotoxins, the ultimate cellular eﬀects
leading to the loss of host cell function are often the same.
Taking this into account we review here the mechanisms of
phagocyte targeting by archetypal exotoxins such as pertussis
toxin (PT) and adenylate cyclase toxin (ACT) secreted by
Bordetella pertussis, anthrax toxin from Bacillus anthracis and
Staphylococcus aureus leukotoxins. We also include here AIP56, a
recently described toxin from Photobacterium damselae piscicida
(Phdp). In addition, the mode of action of mycolactone, a
polyketide molecule produced by Mycobacterium ulcerans, and
other bacterial secreted products not formally termed as toxins,
such as S. aureus superantigens-like proteins (SSLs) and phenol-
soluble modulins (PSMs), are also reviewed here. Clostridial C3
toxins, which target and modulate macrophage functions, are the
focus of another review in this Topic (Barth et al., 2015).
Bordetella pertussis: TWO TOXINS ARE
BETTER THAN ONE
Bordetella pertussis is a Gram-negative pathogen that infects the
human respiratory tract causing whooping cough, an acute and
highly contagious infection (Mattoo and Cherry, 2005; Melvin
et al., 2014). Initially thought to be a toxin-mediated disease
(Pittman, 1984), such as cholera and diphtheria, pertussis disease
is instead the result of the coordinated action of a variety
of bacterial factors that allow bacterial adherence to ciliated
respiratory epithelium, survival to host innate immune defense,
multiplication, and resistance to inﬂammatory cells (Carbonetti,
2007). Two of the major virulence factors of B. pertussis are the
secreted toxins, PT and ACT, which emerged as key elements for
suppression/modulation of the host immune and inﬂammatory
responses (Carbonetti, 2010; Higgs et al., 2012; Melvin et al.,
2014). Interestingly, mouse infections with diﬀerent mutants
suggested that these two toxins have complementary functions
in pathogenesis assaulting the innate immune cells at diﬀerent
times and from diﬀerent angles. PT would act at early stages
of infection mainly inhibiting the recruitment of immune cells,
while ACT would later intoxicate macrophages and neutrophils
blocking bacterial engulfment and destruction (Carbonetti et al.,
2005).
First Round: PT Inflicts First Blow to the
Host
Pertussis toxin is a multisubunit AB-toxin exclusively produced
by B. pertussis. Through B-subunits, PT binds to any sialic
acid-containing glycoprotein at the cellular surface (Witvliet
et al., 1989; Saukkonen et al., 1992; Stein et al., 1994), is
internalized by endocytosis and follows a retrograde transport
pathway through the Golgi complex to the endoplasmic
reticulum (Plaut and Carbonetti, 2008; Figure 1), from which
the A-subunit translocate to the cytoplasm of host cells (Locht
et al., 2011). In the host cell cytosol, the A-subunit exhibits
ADP-ribosyltransferase activity, hydrolysing NAD and ADP-
ribosylating heteromeric G-proteins of the Gi family (Katada
et al., 1983). This modiﬁcation prevents the interaction of Gi
proteins with their cognate G-protein coupled receptors (GPCRs)
causing the disruption of downstream cell signaling transduction
(Mangmool and Kurose, 2011). Besides the activity of the A
domain, B-subunits also display signaling function by activating
intracellular signaling cascades in a Gi-protein independent
manner (Mangmool and Kurose, 2011).
Pertussis toxin has long been considered as a major
B. pertussis virulence factor. Indeed, PT was reported to be
the cause of systemic symptoms of pertussis disease such
as lymphocytosis and leukocytosis (Morse and Morse, 1976)
and was associated with lethal infection by B. pertussis in a
neonatal mouse model (Goodwin and Weiss, 1990). However,
evidences supporting its role in respiratory infection have only
emerged in the last decade. Experiments in the mouse model
revealed that the lack of PT confers a defect in B. pertussis
colonization at the early stages of infection (Carbonetti et al.,
2003, 2005). Interestingly, a PT-deﬁcient strain reaches wild
type levels of colonization whenever co-infections with both
strains are performed or intranasal inoculation of puriﬁed PT
precedes infection (Carbonetti et al., 2003). Further studies
have shown that depletion of resident airway macrophages
leads to exacerbated B. pertussis infection in a PT-independent
manner (Carbonetti et al., 2007), indicating that PT targets
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FIGURE 1 | The concerted action of pertussis toxin (PT) and adenylate cyclase toxin (ACT) annihilates recruitment and function of innate immune
cells. Following binding to a sialoglyprotein receptor, PT is endocytosed and retrogradely transported to the endoplasmic reticulum (ER). From the ER, the A subunit
is delivered into the cytosol and travels to the plasma membrane, where it ADP-ribosylates the alpha-subunit of heterotrimeric G proteins, perturbing their regulatory
functions and leading to an increase in the cAMP concentration that contributes to the early suppression of inflammatory cytokine production and inhibits the
recruitment of immune cells to the site of infection. ACT binds with high affinity to CD11b/CD18 receptor [also known as complement receptor 3 (CR3) or
macrophage-1 antigen (Mac-1)] present at the surface of macrophages, neutrophils, and dendritic cells. Upon binding, ACT integrates the membrane of target cell in
two different conformations: a translocation precursor that relocalises at lipid raft domains from where the adenylate cyclase activity translocates directly to the cell
cytoplasm; and a pore precursor that oligomerises and permeabilises the cells causing ion concentration imbalance. Binding of calmodulin stimulates the adenylate
cyclase, leading to an increase in intracellular levels of cAMP. The activity of ACT inhibits complement-mediated phagocytosis, inhibits the production of
pro-inflammatory cytokines and interferes with immune cell recruitment.
airway macrophages disrupting their protective activity at
early steps of infection (Carbonetti et al., 2007). Intranasal
administration of PT resulted in ADP-ribosylation of airway
macrophages Gi-proteins (Carbonetti et al., 2007), suggesting
that its inhibitory function on macrophages in vivo results from
the immunosuppressive activities ascribed to PT in vitro. In
particular, in vitro PT was shown to inhibit macrophage and
neutrophil migration (Meade et al., 1984), phagocytosis (Mork
andHancock, 1993) and cytokine response (He et al., 1988; Hume
and Denkins, 1989).
In vivo, PT plays a dual role in the establishment of the
disease. Whereas it has immunosuppressive functions at early
stages of infection, later it potentiates inﬂammatory responses,
likely prolonging healing and promoting bacterial dissemination
(Eby et al., 2015). Early in infection, PT targets airway
macrophages and inhibits neutrophil recruitment to the infection
site (Carbonetti et al., 2003, 2005; Kirimanjeswara et al., 2005;
Andreasen and Carbonetti, 2008). Neutrophils were reported
to play a protective role against B. pertussis only in previously
infected mice and in the presence of anti-B. pertussis antibodies
(Kirimanjeswara et al., 2005; Andreasen and Carbonetti, 2009),
which may suggest that PT delays neutrophil recruitment to
the airways avoiding rapid antibody-mediated clearance of the
pathogen. Later, at the peak of infection, high numbers of
neutrophils are recruited to the lungs of mice infected with wild
type strain, but not to those infected with PT-deﬁcient strain
(Carbonetti et al., 2005; Andreasen et al., 2009). This recruitment
of neutrophils to the lungs correlates with an increase of
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proinﬂammatory cytokines such as IL-17, TNFα and IFNγ that
appears to be dependent on PT activity (Andreasen et al., 2009).
Recently, global transcriptional proﬁles of mice lungs infected
with wild type or PT-deﬁcient B. pertussis revealed that, at the
peak of infection, the ADP-ribosylation activity of PT correlates
with upregulation of immune and inﬂammatory response genes
(Connelly et al., 2012). In vitro studies suggested that PT directly
impairs neutrophil migration through ADP-ribosylation the Gi-
proteins associated with surface chemokine receptors (Spangrude
et al., 1985; Scott et al., 1988; Figure 1). However, in vivo
data showed that besides acting directly on chemokine receptors
signaling (Kirimanjeswara et al., 2005), PT also suppresses
early neutrophil recruitment by inhibiting the production
of neutrophil-attracting chemokines by airway macrophages
and lung epithelial cells (Andreasen and Carbonetti, 2008).
Transcription of genes expressing CXCL1, CXCL2, and CXCL5
is inhibited in the lungs of mice intranasally infected with wild
type B. pertussis, as compared to animals infected with strains
deﬁcient for PT production or producing a PT variant devoid
of ADP-ribosylation activity (Andreasen and Carbonetti, 2008).
Interestingly, PT also blocks chemokine gene expression and
early neutrophil recruitment to the airways following intranasal
administration of LPS (Andreasen and Carbonetti, 2008), which
occurs presumably through modulation of TLR-4 signaling, a
Gi-protein independent pathway.
Altogether, these studies show that PT suppresses early
inﬂammation in the respiratory tract and inhibit microbicidal
function of inﬂammatory cells, potentially providing advantage
to the pathogen by allowing its rapid growth and establishment
within the host at early phases of infection.
Second Round: ACT Perpetuates the
Pathogen Gain
Adenylate cyclase toxin is a bi-functional toxin produced
by all species of Bordetella that infect mammals. While its
N-terminal domain contains an adenylate cyclase activity that
converts ATP in cAMP, the C-terminus possesses RTX motifs
that bind mammalian cells and form cation-selective pores in
the host plasma membrane. Through its combined adenylate
cyclase and pore-forming activities, ACT manipulates host cell
physiology in two diﬀerent ways: it interferes with intracellular
signaling by increasing the levels of cAMP, and disturbs ion
homeostasis by disrupting the permeability barrier of the plasma
membrane (Figure 1). ACT speciﬁcally binds with high aﬃnity
CD11b/CD18 (also known as CR3 or Mac-1) present at the
surface of macrophages, neutrophils and dendritic cells (DCs;
Guermonprez et al., 2001). Upon binding, ACT integrates the
membrane of target cells in two diﬀerent conformations: a
translocation precursor that re-localizes at lipid raft domains
from where the adenylate cyclase activity translocates directly
to the cell cytoplasm; and a pore precursor that oligomerises
and permeabilises the cells causing ion concentration imbalance
(Fiser et al., 2007, 2012; Bumba et al., 2010; Figure 1). While the
rapid translocation of adenylate cyclase activity across the host
plasma membrane does not dependent on endocytosis (Gordon
et al., 1988), the clathrin-dependent endocytosis of ACT together
with its receptor CD11b/CD18 was reported (Khelef et al., 2001;
Martin et al., 2011). Classical mechanisms of membrane repair
upon toxin-induced pore formation include the removal of
the pores through endocytosis. Interestingly, ACT-translocated
molecules control the rate of ACT-pore removal delaying their
endocytic uptake, thus exacerbating the permeabilisation of
phagocytes and maximizing the cytotoxic action (Fiser et al.,
2012). Despite its interaction with a speciﬁc receptor, ACT was
reported to promiscuously bind and intoxicate many cell types,
including CD11b/CD18-negative cells (Ladant and Ullmann,
1999; Paccani et al., 2008; Eby et al., 2012), although the biological
relevance of these ﬁndings remains unclear. Indeed, while ACT
triggers macrophage apoptosis in vitro (Khelef et al., 1993;
Khelef and Guiso, 1995) and in vivo (Gueirard et al., 1998),
the viability of cells from non-haematopietic origin remains
unaﬀected (Gueirard et al., 1998; Bassinet et al., 2000). In vivo
studies support that ACT primarily targets phagocytes such
as alveolar macrophages and neutrophils, disrupting the early
innate antibacterial host immune response (Harvill et al., 1999;
Figure 1).
cAMP is a key second messenger with pleiotropic eﬀects.
Increased levels of cAMP severely compromise cellular functions
such as the migration of neutrophils, the plasticity of DC
responses, the release of cytokines by macrophages and
the homeostasis of actin cytoskeleton. Thus, through the
uncontrolled production of intracellular cAMP, ACT subverts
phagocytic, and bactericidal function of macrophages and
neutrophils in a variety of ways (Figure 1). In human alveolar
macrophages and neutrophils, as in mouse macrophages,
the ACT-mediated cAMP production blocks phagocytosis,
chemotaxis, and oxidative burst (Confer and Eaton, 1982;
Friedman et al., 1987;Weingart andWeiss, 2000; Kamanova et al.,
2008; Eby et al., 2014). High levels of cAMP cause a transient
inactivation of RhoA inducing massive actin rearrangements
that dramatically decrease macropinocytosis, block complement-
mediated phagocytosis (Kamanova et al., 2008) and possibly
impair the chemotactic properties of primary monocytes.
Recently, ACT-induced cAMP synthesis was shown to trigger
pro-apoptotic signaling in phagocytes through the activity of
tyrosine phosphatase SHP-1, the accumulation of cytosolic
BimEL and the consequent activation of Bax, permeabilisation
of the outer mitochondrial membrane and activation of
programmed cell death (Ahmad et al., 2015; Cerny et al.,
2015). Besides the immediate action of ACT on the ablation
of bactericidal functions of phagocytes, ACT activity was also
reported to block the release of TNFα and the production of
ROS in human monocytes (Njamkepo et al., 2000), to promote
incomplete or aberrant maturation of DCs (Skinner et al., 2004;
Boyd et al., 2005) and to impair T-cell activation by interfering
with immunological synapse signaling (Paccani et al., 2011). ACT
was described to suppress the secretion of pro-inﬂammatory
cytokines such as IL-12 and TNFα and favor the production of
anti-inﬂammatory IL-10 molecules (Spensieri et al., 2006; Hickey
et al., 2008).
Despite the fact that studies in mouse models established ACT
as an important virulence factor for B. pertussis infection (Khelef
et al., 1992), the eﬀects described above were obtained from
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in vitro studies, and their signiﬁcance during in vivo infection
requires further investigation. Importantly, recent studies using
baboon infection model and clinical samples from humans
showed that the concentration of ACT in tissues is much lower
than the amount used for in vitro experiments (Eby et al., 2013),
which may compromise the relevance of some eﬀects reported
in vitro.
Pertussis toxin and ACT have undeniable roles during
B. pertussis infection and certainly play key functions in the
pathophysiology of pertussis disease. Numerous and wide-
ranging eﬀects of the puriﬁed toxins on cultured cell lines have
been reported, however, establishing the correlation of such
eﬀects with the human pathology appeared as an incredible
diﬃcult task. In addition, the mouse model only provides limited
possibilities to address this issue. Together with analysis of
clinical samples from humans, the use of baboons as non-human
primate model is expected to shed new light on the mechanisms
of action of PT and ACT and on pertussis disease.
Bacillus anthracis: ARMED TO
ANNIHILATE THE HOST INNATE
IMMUNE DEFENSES
Bacillus anthracis is a Gram-positive, spore-forming rod that
causes anthrax, an acute and fast progressing disease that aﬀects
humans and other animals, and results from a combination
of bacterial infection and toxemia (Moayeri et al., 2015). The
spores, which are the infectious form of the pathogen, are
able to resist harsh environmental conditions and to infect
new hosts when inhaled, ingested, or exposed to skin breaks.
Upon entering a potential host, spores germinate into vegetative
bacilli that replicate and disseminate through the bloodstream,
leading to a systemic infection. Whereas in experimental
inhalational anthrax, spore germination requires engulfment
by macrophages/DCs (Guidi-Rontani et al., 1999; Hanna and
Ireland, 1999), in experimental cutaneous infections it has been
shown that most of the spore germination occurs extracellularly
(Bischof et al., 2007; Corre et al., 2013). Soon after spore
germination, vegetative B. anthracis start producing two potent
exotoxins – anthrax lethal toxin (LT) and edema toxin (ET) –
that along with a poly-D-glutamic acid capsule, are its major
virulence factors (Moayeri et al., 2015). B. anthracis also secretes
anthrolysin O (ALO), a member of the cholesterol-dependent
cytolysin family (Shannon et al., 2003). ALO is cytotoxic for
several mono- and polymorphonuclear cells (Shannon et al.,
2003; Cocklin et al., 2006; Mosser and Rest, 2006) and together
with LT, induces apoptosis of macrophages (Shannon et al.,
2003). However, ALO-deﬁcient and wild-type strains revealed
no diﬀerences in virulence in an inhalation infection model
(Heﬀernan et al., 2007). Consistent with these observations,
ALO-based vaccines, although conferring protection against
lethal intravenous challenge with ALO, do not protect mice
against peritoneal infection by B. anthracis (Cowan et al., 2007).
Altogether, available data indicate that ALO is not essential for
B. anthracis virulence and thus further studies are needed to
determine if ALO contributes to B. anthracis pathogenicity.
Anthrax toxins originate from the association of three
diﬀerent protein components: a host cell receptor binding protein
named protective antigen (PA) and two enzymatic proteins,
edema factor (EF) and lethal factor (LF) (Young and Collier,
2007; Figure 2). EF or LF associated to PA is referred as
ET or LT, respectively. Host cell intoxication begins when
PA binds to either tumor endothelium marker 8 (TEM8, also
known as anthrax toxin receptor 1, ANTXR1) or capillary
morphogenesis protein 2 (CMG2, also known as anthrax toxin
receptor 2, ANTXR2), which are expressed by diﬀerent cell
types, including macrophages and neutrophils (Bradley et al.,
2001; Scobie et al., 2003). Although both TEM8 and CMG2 can
function as anthrax toxin receptors, studies with TEM8- and
CMG2-null mice have shown that CMG2 is the major anthrax
toxin receptor mediating toxin lethality in vivo and that TEM8
plays only a minor role in anthrax toxin-associated pathogenesis
(Liu et al., 2009). Upon binding to its cell surface receptor,
PA is proteolytically processed at its N-terminus by a furin-like
protease and self-assembles forming an oligomeric prepore able
to bind EF and LF. The EF and/or LF-prepore-receptor complex
undergoes receptor-mediated endocytosis (Abrami et al., 2003)
and the acidic conditions in endosomes induce conversion of
the prepore to a pore, allowing translocation of EF and LF into
the cell cytosol (Collier, 2009) to exert their cytotoxic eﬀects
(Figure 2). In endosomes, the toxin complex can also be sorted
into intraluminal vesicles that undergo back fusion with the
endosomal membrane allowing sequestered EF and LF to reach
the cytosol (Abrami et al., 2004).
The toxicity of LT and ET results from the catalytic activities
of LF and EF. LF is a zinc-dependent metalloprotease that cleaves
mitogen activate protein kinase (MAPK) kinases (MKK) 1-4 and
6-7, preventing the activation of the ERK1/2, p38 and JNK-
pathways (Duesbery et al., 1998; Pellizzari et al., 1999; Vitale et al.,
2000; Tournier et al., 2005) and thus interfering with critical
signaling pathways involved in host defense (Figure 2). EF is a
calmodulin- and Ca2+-dependent adenylate cyclase that causes
a sustained increase of cAMP (Leppla, 1982) by converting ATP
to cAMP. As discussed above in the context of the ACT from
B. pertussis, increased cAMP levels perturb key cellular functions,
leading to severe consequences for the host (Leppla, 1982; Firoved
et al., 2005).
Anthrax toxins: Weapons to Cripple Host
Macrophages and Neutrophils
Anthrax has for long been described as a toxin-mediated disease,
mainly because LT and ET can be lethal for experimental
animals and anti-toxin immunization is eﬀective in protecting
against infection (Kaur et al., 2013). However, it has recently
been proposed that extreme bacteraemia and severe sepsis
rather than the anthrax toxins per se are the cause of anthrax-
induced lethality (Coggeshall et al., 2013). Indeed, the fact that
anthrax toxins act on multiple tissues simultaneously, due to the
ubiquitous expression of the anthrax toxin receptors, complicate
untangling their eﬀects on the host and delayed the identiﬁcation
of the key tissue targets responsible for its lethal eﬀects. Recently,
using cell-type speciﬁc CMG2-null mice and the correspondent
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FIGURE 2 | Anthrax toxins cooperatively disable host innate immune response. Host cell intoxication by anthrax toxins involves interaction of protective
antigen (PA, 83 kDa) with two cellular receptors [tumor endothelium marker 8 (TEM8), also known as anthrax toxin receptor 1 (ANTXR1) and capillary morphogenesis
protein 2 (CMG2) also known as anthrax toxin receptor 2 (ANTXR2)], which are expressed by different cell types, including macrophages and neutrophils. Upon
binding to the cell surface receptor, PA83 is proteolytically processed at its N-terminus by a furin-like protease yielding the C-terminal fragment PA63 that
oligomerises into a heptameric prepore able to bind edema factor (EF) and lethal factor (LF). The EF and/or LF-prepore-receptor complex undergoes
receptor-mediated endocytosis and the acidic conditions in endosomes induce conversion of the prepore to a pore, allowing translocation of EF and LF into the cell
cytosol to exert their cytotoxic effects. LT is a zinc-dependent metalloprotease that inhibits activation of neutrophils and macrophages, expression of inflammatory
cytokines and cell motility by disrupting mitogen activated protein kinase kinases (MAPKKs)-regulated pathways. LT activity also promotes macrophage apoptosis by
interfering with pro-survival MAPKK dependent pathways. ET is a calcium and calmodulin-dependent adenylate cyclase that increases intracellular cAMP
concentration, leading to the suppression of the expression of inflammatory cytokines and cell chemotaxis through protein kinase A (PKA)-dependent pathways. The
concerted action of LT and ET blocks the function of phagocytic cells.
cell-type speciﬁc CMG2-expressing mice, Liu and colleagues
have shown that LT-induced mortality requires targeting of
cardiomyocytes and vascular smooth muscle cells, whereas ET-
induced lethality reliesmainly on targeting hepatocytes (Liu et al.,
2013). Using myeloid-speciﬁc CMG2-null mice, in which both
macrophages and neutrophils are insensitive to LT and ET due to
their inability to bind and internalize the toxins, the same authors
have also clariﬁed the role of macrophages and other myeloid
cells in anthrax toxins induced lethality and in B. anthracis
infection (Liu et al., 2010). Myeloid-speciﬁc CMG2-null mice
are fully sensitive to both LT and ET, indicating that lethality
does not depend on the targeting of macrophages, neutrophils,
and other myeloid cells (Liu et al., 2010). However, they are
completely resistant to infection by B. anthracis, indicating that
the targeting of myeloid cells by anthrax toxins is required for
the establishment of a successful infection (Liu et al., 2010). In
what concerns the relative contributions of ET and LT to the
establishment of B. anthracis infection, trials with Sterne strains
deleted of PA, LF, or EF suggest that LT plays a more prominent
role (Liu et al., 2010).
Available data indicate that LT and ET act in concert to
inhibit macrophage activation as well as the activation and
recruitment of other immune cells, such as neutrophils, early
in infection (Baldari et al., 2006; Tournier et al., 2009; Liu
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et al., 2014). This favors bacterial escape and multiplication,
and contributes to the severe bacteraemia observed in terminal
disease. Macrophage activation requires signaling through
MAPK cascades, including JNK and p38 pathways, which are
central for induction of inﬂammatory molecules, including
cytokines and chemoattractants, as well as Cox-2 and iNOS. LT
interrupts MAPK cascades by directly cleaving MAPKK, whereas
ET inhibits MAPK-dependent gene expression by interfering
with multiple PKA-related pathways (Baldari et al., 2006). Several
reports show that LT inhibits the secretion of pro-inﬂammatory
cytokines by macrophages as well as by DCs in vitro and in vivo
(Pellizzari et al., 1999; Erwin et al., 2001; Agrawal et al., 2003;
Alileche et al., 2005; Bergman et al., 2005; Brittingham et al., 2005;
Tournier et al., 2005; Ribot et al., 2006). ET has been shown to
suppress secretion of inﬂammatory mediators by DCs (Tournier
et al., 2005).Whereas LT inhibits IL-10 secretion by these cells, ET
inhibits IL12p70 production (Tournier et al., 2005). Interestingly,
LT and ET have a cumulative suppressive eﬀect upon TNFα
secretion (Tournier et al., 2005). In addition to suppress pro-
inﬂammatory cytokine secretion by macrophages, LT is also able
to trigger programmed cell death in these cells in vitro. Indeed,
it has been reported that LT induced apoptosis of RAW264.7
cells (Popov et al., 2002). Furthermore, although treatment of
three diﬀerent human monocytic cell lines (HL-60, THP-1, and
U937) did not result in cell death, upon diﬀerentiation into
macrophage-like phenotypes, the cells become susceptible to a
cell death program that has features of apoptosis but apparently
does not requires the activity of eﬀector caspases (Kassam et al.,
2005). The apoptogenic activity of LT toward macrophages likely
relates to LT-dependent disruption of survival signals triggered by
TLR4 and mediated by p38 MAPK (Park et al., 2002, 2005; Hsu
et al., 2004) that activates the NF-kB-dependent expression of
pro-survival genes. By cleaving the upstreamMAPKKMKK3, LT
blocks p38 MAPK and NF-kB activation, leading to macrophage
apoptosis (Huang et al., 2004; Park et al., 2005).
Lethal toxin has also been shown to induce a rapid and lytic
form of caspase-1-dependent cell death, called pyroptosis, in
macrophages from speciﬁc rat andmice strains. The susceptibility
of macrophages to pyroptosis has been linked to polymorphisms
of the Nlrp1b gene in mice (Boyden and Dietrich, 2006)
and of the orthologous Nlrp1 gene in rat (Newman et al.,
2010). The ability of LT to induce macrophage pyroptosis was
initially interpreted as a virulence mechanism of B. anthracis
(Muehlbauer et al., 2007). It was speculated that the destruction
of macrophages by LT compromised their role in restricting
B. anthracis infection and that the cytokine burst associated
to LT-induced macrophage lysis contributed to LT-dependent
pathological eﬀects by aggravating the vascular damage occurring
in anthrax (Muehlbauer et al., 2007). More recently, it has
been shown that LT is able to directly cleave mouse Nlrp1b
and rat Nlrp1 close to their N-terminus (Hellmich et al.,
2012; Levinsohn et al., 2012; Chavarria-Smith and Vance, 2013)
resulting in the activation of Nlrp1 inﬂammasomes in rat and
in mice with LT-sensitive macrophages. Ultimately, this leads
to caspase-1 activation and pyroptosis accompanied by the
release of the inﬂammatory cytokines IL-1β and IL-18, which
induces a strong innate immune response that is protective
against B. anthracis infection (Moayeri et al., 2010; Terra
et al., 2010). Therefore, the current view is that LT-mediated
activation of Nlrp1 that leads to inﬂammasome activation and
macrophage pyroptosis is not a virulence mechanism used
by B. anthracis to promote infection, but rather a protective
host-response against anthrax (Chavarria-Smith and Vance,
2015).
Neutrophils play a major role in controlling B. anthracis
infection and anthrax-toxin mediated neutralization of
neutrophil functions is essential for successful infection
(Liu et al., 2010). In vitro studies suggest that by reducing
F-actin formation, LT and ET cooperate to inhibit neutrophil
chemotaxis, chemokinesis, and ability to polarize (During et al.,
2005, 2007; Szarowicz et al., 2009). It was also reported that
neutrophils intoxicated with ET have reduced phagocytic activity
(O’Brien et al., 1985). Additionally, LT has been shown to
suppress cytokine production by neutrophils in vitro (Barson
et al., 2008) and LT and ET were found to block neutrophil
priming by LPS or muramyl dipeptide, thereby dampening
the oxidative burst normally elicited by bacterial products and
required for full antimicrobial activity (Wright and Mandell,
1986). In the case of ET, it has been shown that the inhibition
of superoxide production results from an impairment of the
activation of the neutrophil NADPH oxidase, an eﬀect that likely
results from the activity of ET as an adenylate cyclase (Crawford
et al., 2006). Although it has been proposed that these eﬀects are
due to the ET-induced rise in cAMP leading to phosphorylation
(activation) of PKA (Szarowicz et al., 2009), the downstream
targets remain to be identiﬁed.
It is now unquestionable that anthrax toxins are crucial in
anthrax pathogenesis, but their precise roles during human
anthrax infections remain to be further clariﬁed. Following the
discovery of the anthrax toxins more than half a century ago,
a myriad of studies were developed aiming at deﬁning their
role in anthrax disease and lethality. However, most of the
infection studies were performed in animal models that may not
completely reﬂect the events occurring during human infections.
Concerning the data documenting the immunomodulatory
eﬀects of the anthrax toxins, most were obtained in vitro, often in
experimental set-ups that involve the use of puriﬁed toxins and
do not allow examining intoxication in the context of infection.
Therefore, the available data need to be validated in the context
of relevant animal models of infections before being extrapolated
to the human disease scenario.
Photobacterium damselae piscicida:
KILLING TWO BIRDS WITH ONE STONE
Photobacterium damselae piscicida is a Gram-negative
extracellular bacterium that causes a systemic and deadly
infection with a rapid course and very high mortalities in both
wild and cultured marine ﬁsh (Romalde, 2002; Barnes et al.,
2005). Phdp infections are characterized by the occurrence
of generalized bacteraemia and extensive cytopathology with
abundant tissue necrosis (do Vale et al., 2007). Infected ﬁsh
often present whitish tubercle-like lesions of about 0.5 to
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3.5 mm in diameter in several internal organs (Tung et al., 1985;
Hawke et al., 1987; Noya et al., 1995; Magariños et al., 1996; do
Vale et al., 2007), leading to the coining of the disease as ﬁsh
pseudotuberculosis (Kubota et al., 1970). The lesions consist
of accumulations of bacteria and apoptotic and necrotic cell
debris (Kubota et al., 1970; Hawke et al., 1987; do Vale et al.,
2007).
Photobacterium damselae piscicida-associated pathology is
triggered by AIP56 (apoptosis inducing protein of 56 kDa), a
plasmid-encoded toxin secreted by virulent Phdp strains (do
Vale et al., 2005). The toxin is systemically disseminated in
infected animals and induces selective apoptotic destruction of
macrophages and neutrophils (do Vale et al., 2003, 2005, 2007).
The simultaneous destruction of these cell types by AIP56 has
two dramatic consequences for the host. On one hand, the drastic
reduction of the number of phagocytes impairs the phagocytic
defense, favoring pathogen dissemination (do Vale et al., 2007).
On the other hand, it compromises the host capacity to clear
apoptosing cells, leading to the lysis of the phagocytes by post-
apoptotic secondary necrosis with consequent release of their
highly cytotoxic tissue-damaging contents (do Vale et al., 2007;
Silva et al., 2008).
AIP56: Spreading the Misery by Killing
the Soldiers and Preventing their Burial
AIP56 is the founding and the only characterized member of
a continuously growing family of bacterial proteins identiﬁed
in diﬀerent organisms, mainly marine Vibrio species and
Arsenophonus nasoniae. It is an AB-type toxin, possessing a
catalytic A domain at its N-terminal region and a B domain
involved in binding/internalization into target cells at its
C-terminal region (Silva et al., 2013; Figure 3). The catalytic
domain of AIP56 is a zinc-dependent metalloprotease that cleaves
the p65 subunit of NF-κB (Silva et al., 2013), an evolutionarily
conserved transcription factor that regulates the expression of
inﬂammatory and anti-apoptotic genes, playing a key role in
host responses to microbial pathogen invasion. AIP56 has likely
originated from a fusion of two components: its A domain is
related to NleC, a type III secreted eﬀector present in several
enteric pathogenic bacteria (Yen et al., 2010; Baruch et al., 2011;
Pearson et al., 2011; Sham et al., 2011; Hodgson et al., 2015) that
are associated with severe human illness and death worldwide,
whereas its B domain is related to a protein of unknown function
from the lambda-like bacteriophage APSE2, a phage that infects
Hamiltonella defensa (Degnan et al., 2009).
Although mammals are not susceptible to Phdp infection,
likely due to temperature and osmolality restrictions, AIP56 is
able to intoxicate mouse bone marrow derived macrophages
(mBMDM; Pereira et al., 2014), through a mechanism similar
to the one operating during intoxication of ﬁsh cells. Upon
encountering susceptible cells, AIP56 binds to a still unidentiﬁed
cell-surface receptor and is internalized through clathrin-
mediated endocytosis (Pereira et al., 2014; Figure 3). Once in
early endosomes, the toxin either follows the recycling pathway
back to the extracellular medium or undergoes low pH-induced
translocation across the endosomal membrane into the cytosol
to display its toxic activity (Pereira et al., 2014). AIP56 cleaves
an evolutionarily conserved peptide bond of the Rel homology
domain of NF-κB p65, removing residues crucial for p65-DNA
interaction and compromising NF-κB activity (Silva et al., 2013;
Figure 3). During intoxication, the proteolytic activity of AIP56
results in a complete depletion of p65 and leads to the apoptotic
death of cells (Silva et al., 2013; Pereira et al., 2014) through a
process involving quick activation of caspases-8, -9 and -3, loss of
mitochondrial membrane potential, translocation of cytochrome
c to the cytosol and overproduction of ROS (do Vale et al., 2007;
Reis et al., 2007a,b, 2010; Costa-Ramos et al., 2011).
AIP56 plays a pivotal role in the establishment of Phdp
infection and in the development of the infection-associated
pathology. In the initial phase of Phdp infection, when local
multiplication of Phdp becomes detectable in infected tissues,
extensive inﬁltration of macrophages and neutrophils occurs (do
Vale et al., 2007). As the infection progresses, the pathogen
extensively multiplies and disseminates systemically, which leads
to a septicemic situation paralleled by the occurrence of AIP56
in the systemic circulation (do Vale et al., 2007). The presence of
circulating toxin correlates with the appearance of high numbers
of apoptotic macrophages and neutrophils in the peripheral
blood, in the spleen, liver, and head–kidney vasculature, as
well as in the splenic and head-kidney parenchyma and gut
lamina propria (do Vale et al., 2007). This systemic apoptotic
destruction of macrophages and neutrophils triggered by AIP56
explains the extensive phagocyte depletion observed in advanced
Phdp infections (do Vale et al., 2007). The ability of the toxin
to neutralize the main players responsible for the phagocytic
defense of the host is a very eﬀective pathogenicity strategy
that contributes to the severity of Phdp infections by promoting
survival of the pathogen and its unrestricted extracellular
multiplication. Concomitantly, the AIP56-induced apoptosis
of both professional phagocytes leads to tissue damage with
deleterious consequences for the host. In fact, the destruction
of macrophages, the cells with the crucial role of eliminating
apoptotic cells (Parnaik et al., 2000; Wood et al., 2000),
compromises the eﬃcient clearance of apoptotic phagocytes and
leads to their lysis by secondary necrosis (do Vale et al., 2003)
with release of their cytotoxic intracellular contents (doVale et al.,
2007). This has particularly serious consequences in the case of
neutrophils, due to their richness in highly cytotoxic molecules,
which damage many cell types and produce tissue injury, thus
contributing to the genesis of the Phdp-associated cytopathology.
Staphylococcus aureus: A BENCH OF
SECRETED MOLECULES TO SHOOT
NEUTROPHILS
Staphylococcus aureus is a Gram-positive bacterium that often
colonizes the human nares and the skin. Besides being a
commensal, S. aureus is also a redoubtable human pathogen that
causes a variety of severe diseases. To set up a successful infection,
S. aureus evolved an amazing variety of immune evasive strategies
wiping out both innate and adaptive immune responses. S. aureus
infections involve the invasion of host tissues, replication in
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FIGURE 3 | AIP56 blocks innate immunity by inducing massive apoptosis of host macrophages and neutrophils. Upon encountering susceptible cells,
apoptosis-inducing protein of 56 kDa (AIP56) binds to a still unidentified cell-surface receptor and undergoes clathrin-mediated endocytosis. Once in early
endosomes, the toxin either follows the recycling pathway back to the extracellular medium or suffers low pH-induced translocation across the endosomal
membrane into the cytosol to display its toxic activity. AIP56 is a zinc-dependent metalloprotease that cleaves the p65 subunit of nuclear factor-κB (NF-κB), an
evolutionarily conserved transcription factor that regulates the expression of inflammatory and anti-apoptotic genes and plays a key role in host responses to
microbial pathogen invasion. During infection, AIP56 disseminates systemically and its activity leads to depletion of macrophages and neutrophils by post-apoptotic
secondary necrosis, thereby blocking the phagocytic defense of the host and contributing to the occurrence of tissue damage.
abscess lesions and dissemination through purulent drainage
of these lesions and require the recruitment of immune cells
to the site of infection. Such inﬁltrated immune cells would
usually eliminate the bacteria. However, to counter their action,
S. aureus secretes soluble molecules targeting multiple pathways
to manipulate the capacity of neutrophils for chemotaxis,
phagocytosis, and bacterial killing, thus enabling pathogen
replication and ensuring the success of the infection. Several
recent and comprehensive reviews highlight how S. aureus
virulence factors manipulate the host immune response (Spaan
et al., 2013b; Otto, 2014; Thammavongsa et al., 2015). Here we
will focus on its secreted molecules mainly targeting neutrophils,
modulating their function, or inducing cell killing.
Avoiding Neutrophil Extravasation,
Chemotaxis, and Activation
In general, upon pathogen recognition, pro-inﬂammatory signals
released by resident macrophages promote the adhesion of
circulating neutrophils and further extravasation across capillary
endothelium to the site of infection. This process relies on
interactions between the endothelial surface receptors (e.g.,
selectins and ICAM1) and their respective ligands on the
surface of neutrophils (e.g., PSGL1 and β2-integrin) (Spaan
et al., 2013b). To inhibit neutrophil recruitment to the infected
tissues, S. aureus secretes two anti-inﬂammatory factors that
prevent neutrophil adhesion to the blood vessels and further
transmigration (Figure 4A). The staphylococcal SSL5 binds
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PSGL1 in a glycan dependent manner at the surface of
neutrophils, blocking its interaction with P-selectin expressed
by endothelial cells and abrogating the early steps of neutrophil
attachment (Bestebroer et al., 2007). In addition, SSL5 was
shown to inactivate matrix metalloproteinase from human
neutrophils, accounting for the limited capacity of neutrophils
to transmigrate into infected tissues (Itoh et al., 2010). The
extracellular adherence protein (Eap) recognizes endothelial
ICAM1, preventing its interaction with β2-integrins at the surface
of neutrophils and further inhibiting extravasation (Chavakis
et al., 2002).
Staphylococcus aureus also secretes a number of antagonists
of neutrophil receptors interfering with chemokine signaling and
limiting neutrophil recruitment (Figure 4A). In particular, SSL5
directly binds the N-terminus of G-protein coupled chemokine
receptors (GPCRs) inhibiting calcium mobilization and actin
polymerization, thus impairing neutrophil responses to a huge
diversity of chemokines (e.g., CXCL8, CXCL1, CCL2, and CCL5)
and to complement fragments C3a and C5a (Bestebroer et al.,
2009). Similarly to the recognition of PSGL1 by SSL5, binding to
GPCRs relies on the presence of sialic acid residues (Baker et al.,
2007; Bestebroer et al., 2007, 2009). In addition, SSL5 was shown
to bind to platelet glycoproteins, inducing platelet activation
and aggregation, which could be important for colonization and
immune evasion by S. aureus (de Haas et al., 2009). SSL10 inhibits
CXCL12-mediated responses by targeting CXCR4 (Walenkamp
et al., 2009) and SSL3 binds to TLR2, hindering immune
recognition of staphylococcal lipoproteins and peptidoglycan
(Yokoyama et al., 2012).
Phenol-soluble modulins are produced by all S. aureus strains
and have multiple roles in staphylococcal pathogenesis (Cheung
et al., 2014a). In particular, PSMs are potent pro-inﬂammatory
molecules that interact with human formyl peptide receptor
2 (FPR2) (Kretschmer et al., 2010), a GPCR involved in the
recognition of pathogens. At nanomolar concentrations, PSMs
bind to and activate FPRs, with the strongest activation occurring
through FPR2, stimulating several FPRs eﬀector functions such
as chemotaxis and pro-inﬂammatory cytokine production (e.g.,
CXCL8; Fu et al., 2006). However, human isolates of S. aureus
evolved other strategies to counter neutrophil chemotaxis by
directly interfering with FPRs signaling and limiting cytotoxicity
while promoting bacterial replication (McCarthy and Lindsay,
2013; Cheung et al., 2014b). Inhibition of FPRs-mediated
pro-inﬂammatory signaling occurs via the secretion of the
chemotaxis-inhibitor protein of S. aureus (CHIPS) (de Haas
et al., 2004) and the FPR2/ALS-inhibitory protein (FLIPr) and
its homologue FLIPrL (Prat et al., 2006, 2009; Figure 4A).
While CHIPS binds and inhibits FPR1 and C5aR, FLIPr
and FLIPrL block FRP2-mediated signaling, thus avoiding
recognition of PSMs secreted by S. aureus, impairing pro-
inﬂammatory response and reducing neutrophil recruitment
(Haas et al., 2004, 2005; Prat et al., 2006, 2009). Clearly,
CHIPS, FLIPr and FLIPrL, and PSMs have opposite eﬀects
on FPRs activation. Thus the production/secretion of these
bacterial molecules is likely to be under strict control to
allow the establishment of the infection and to evade immune
recognition.
The repertoire of secreted molecules by S. aureus to evade
the early steps of immune response also include Stathopain
A (ScpA), a cysteine protease that speciﬁcally cleaves the
N-terminus of human CXCR2 (Laarman et al., 2012), a
GPCR responding to several chemokines (e.g., CXCL1-3 and
CXCL5-8). Stathopain A inhibits CXCR2-mediated calcium
mobilization, migration, intracellular signaling and activation
of neutrophils (Laarman et al., 2012), appearing as an
important immunomodulatory molecule causing neutrophil
unresponsiveness to several chemokines and blocking their
recruitment to the site of infection.
Blocking Complement Activation,
Opsonization, and Phagocytosis
Staphylococcus aureus display intrinsic physical features (e.g.
thick peptidoglycan layer and capsule) that confer resistance to
complement-mediated killing and neutrophil phagocytosis. In
addition, S. aureus secretes a variety of highly speciﬁc proteins
with complement-modulating functions (Figure 4B), thereby
delaying the innate immune attack and generating a window
of opportunity to replicate and establish within the host (Spaan
et al., 2013b; Thammavongsa et al., 2015). Several of these
secreted molecules target C3 or C3 convertases, both central
molecules in the complement activation cascade. Aureolysin is
a metalloproteinase that cleaves C3, generating a modiﬁed C3b
fragment that is further degraded instead of being covalently
linked to the bacterial surface where it would promote the
generation of the chemoattractant molecule C5a (Laarman et al.,
2011). In addition, this proteinase degrades human antimicrobial
peptides highly potent against S. aureus (Sieprawska-Lupa et al.,
2004). Thus, aureolysin activity promotes infection by blocking
the complement cascade impairing bacterial C3b opsonization,
phagocytosis, and neutrophil-mediated killing (Sieprawska-Lupa
et al., 2004; Laarman et al., 2011). Staphylococcal component
inhibitor (SCIN) speciﬁcally binds to human C3 convertase
and blocks its activity thereby preventing the production
of C3a, C3b, and C5a, thus interfering with complement
activation and with neutrophil-mediated killing of S. aureus
(Rooijakkers et al., 2005a, 2009; Figure 4B). In addition, S. aureus
secreted extracellular ﬁbrinogen-binding protein (Efb) together
with its homologue extracellular complement-binding protein
(Ecb), were shown to inhibit both C3 and C5 convertases
(Jongerius et al., 2010a,b, 2007). Other S. aureus secreted
proteins target both C3 and immunoglobulin binding, thus
impairing complement activation and opsonization, this is
the case of staphylococcal binder of immunoglobulin (Sbi;
Haupt et al., 2008) and staphylokinase (Rooijakkers et al.,
2005b).
Besides their role in blocking neutrophil extravasation
and chemotaxis (described above), some SSLs also hinder
complement activation and phagocytosis. SSL7 binds IgA and
complement C5, inhibiting the production of C5a and further
phagocytosis and bacterial clearance during in vivo infection
(Bestebroer et al., 2010). SSL10 binds to IgG1 preventing
recognition by Fc Receptors (FcR), thus impairing IgG1
opsonization and phagocytosis (Patel et al., 2010; Figure 4B).
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FIGURE 4 | Continued
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FIGURE 4 | Continued
Strategies evolved by Staphylococcus aureus to counteract innate immune response. (A) Secreted bacterial factors that inhibit neutrophils extravasation,
chemotaxis and activation. Neutrophil rolling is modulated by staphylococcal superantigen-like 5 (SSL5) that binds P-selectin glycoprotein ligand-1 (PSGL-1),
blocking its interaction with P-selectin. The adhesion of neutrophils to the endothelium and consequent transmigration is inhibited by extracellular adherence protein
(Eap), which binds to intercellular adhesion molecule 1 (ICAM-1). In addition to inhibiting PSGL-1, SSL5 inhibits neutrophil responses to chemokines and to
anaphylatoxins, by binding to different chemokine receptors. Several staphylococcal molecules impair neutrophil chemotaxis and important co-signaling events
during migration and phagocytosis: chemotaxis-inhibitor protein of S. aureus (CHIPS) binds and inhibits formyl peptide receptor 1 (FPR1) and C5a receptor (C5aR);
formyl peptide receptor-like 1 inhibitor (FLIPr)-like inhibit FPR1; FLIPr and FLIPr-like inhibit FPR2; staphopain (ScpA) cleaves Chemokine (C–X–C Motif) Receptor 2
(CXCR2); staphylococcal SSL3 inhibits toll-like receptor 2 (TLR2)-mediated signaling, the bicomponent leukocidins Panton-Valentine leukocidin (PVL),
gamma-hemolysin (Hlg) ABC, leukocidin (Luk) FM, Luk GH/AB, and Luk DE interact with chemoattractant receptors of the G-protein-coupled receptor (GPCR)
family. Both Hla and Luk GH/AB induce cell lysis by binding ADAM metallopeptidase domain 10 (ADAM10) and CD11b, respectively. The cytolytic peptides
phenol-soluble modulins (PSMs) have an amphipathic alpha-helical region that likely contributes to their lytic activity, presumably by membrane insertion and pore
formation. (B) Secreted bacterial factors that inhibit opsonization and phagocytosis by neutrophils. The secreted metalloprotease aureolysin inhibits phagocytosis
and killing of bacteria by neutrophils by cleaving C3. Staphylococcal complement inhibitor (SCIN), SCIN-B, and SCIN-C associate with and inhibits C3 convertase,
thereby preventing the production of C3a, C3b, and further C5a and consequently interfering with complement activation. The extracellular fibrinogen binding protein
(EFB) and the extracellular complement-binding protein (ECB) also inhibit complement activation by inactivating C5 convertase and staphylococcal SSL7 targets C5.
Staphylococcal binder of immunoglobulin (SBI) affect both the function of complement and immunoglobulin binding, blocking the classical complement activation
pathway, and associates with C3 inhibiting the alternative pathway. Staphylokinase (SAK) forms enzymatically active complexes with C3b blocking complement
activation. Staphylococcal SSL10 binds IgG, affecting Fc receptor (FcR) recognition and complement activation.
Avoiding NET Bactericidal Activities
In addition to phagocytosis and intracellular killing, neutrophils
evolved an alternative defense mechanism to trap extracellular
pathogens and prevent their dissemination. This strategy
relies on the release of nuclear content together with
antimicrobial cytosolic and granular proteins to form neutrophil
extracellular traps (NETs), which are scaﬀolds that act as
physical barriers to pathogen progression protecting host
tissues from damage (Papayannopoulos and Zychlinsky,
2009). A secreted staphylococcal nuclease (Nuc) has the
capacity to degrade NETs thereby allowing S. aureus to
resist their bactericidal activities in vitro as well as in a
respiratory tract infection model (Berends et al., 2010). NET
degradation by Nuc leads to the production of monophosphate
nucleotides that are further converted into deoxyadenosine
through the activity of adenosine synthase (AdsA), another
S. aureus secreted protein. Interestingly, the accumulation
of deoxyadenosine generated by AdsA activity promotes the
autocleavage of pro-caspase-3, triggering caspase-3-induced
apoptosis of inﬁltrating macrophages (Thammavongsa et al.,
2013). Together, staphylococcal Nuc and AdsA act in a
concerted mode to promote bacterial survival in S. aureus
abscesses, by excluding macrophages from the infection
foci.
Neutrophil Killing: The Ultimate Defense
In line with its ability to evade almost every step of the innate
immune response, S. aureus induce the death of innate immune
cells, trough the secretion of PSMs and several other toxins. As
mentioned above, PSMs are S. aureus secreted molecules with
multiples roles in infection (Wang et al., 2007; Cheung et al.,
2014a). They trigger inﬂammatory responses by interacting with
FPR2 and display, at higher concentrations, FPR2-independent
cytolytic activity likely through membrane insertion and pore
formation (Kretschmer et al., 2010; Figure 4A). In particular,
PSMα peptides are able to trigger the lysis of the phagosome after
neutrophil ingestion allowing intracellular bacterial replication,
and ultimately are responsible for lysis of neutrophils promoting
bacterial survival and escape to the extracellular milieu (Wang
et al., 2007; Geiger et al., 2012; Chatterjee et al., 2013; Grosz
et al., 2014). In vitro, expression levels of PSMs correlate
with levels of cytotoxicity (Rasigade et al., 2013). Moreover,
mutants deﬁcient for PSMα production are perturbed in
bioﬁlm formation (Peschel and Otto, 2013) and attenuated in
the mouse bloodstream infection model (Wang et al., 2007).
Altogether, these observations strongly suggest that PSMα-
triggered eﬀects may play a key role in in vivo S. aureus
infection.
In addition to PSMs whose cytolytic activity is receptor-
independent, S. aureus secretes other cytolytic toxins that
interact with speciﬁc receptors at the surface of eukaryotic
cells, oligomerize and form pores inducing cell leakage and
ultimately total lysis. S. aureus-produced toxins targeting
white blood cells belong to the beta-barrel pore-forming
toxins and comprise hemolysin-α (Hla, also called α-toxin)
and bicompetent leukocidins (Otto, 2014; Thammavongsa
et al., 2015; Figure 4A). In vivo infection studies have
shown that Hla is required for several S. aureus-associated
pathologies, such as pneumonia and severe skin infections
(Bubeck Wardenburg et al., 2007; Bubeck Wardenburg and
Schneewind, 2008; Kennedy et al., 2010). Hla interacts with high
aﬃnity with ADAM10 at the surface of host cells (Wilke and
Bubeck Wardenburg, 2010) to damage epithelial, endothelial
and immune cells (Berube and Bubeck Wardenburg, 2013;
Figure 4A). Mice lacking ADAM10 expression in the lung
epithelium resist to lethal pneumonia (Becker et al., 2014),
whereas animals lacking ADAM10 speciﬁcally on myeloid
lineage develop exacerbated skin infections (Inoshima et al.,
2011). Although these results suggest that the outcome of Hla-
mediated eﬀects may dependent on the infected tissue, the
role of Hla on tissue-speciﬁc innate immunity requires further
analysis.
Leukocidins are composed by two distinct and independently
secreted subunits that form heteromultimeric pores in the
membrane of host myeloid cells (Otto, 2014). S. aureus
produce diﬀerent arrays of leukocidins with diﬀerent species
and cell type speciﬁcities, which are mainly dictated by their
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interaction with host GPCRs (Spaan et al., 2013b; Otto, 2014;
Thammavongsa et al., 2015; Figure 4A). In vitro assays with
puriﬁed proteins, as well as ex-vivo infections with S. aureus,
have shown that leukocidin AB (LukAB, also called LukGH)
kills human, but not mouse, neutrophils upon binding to
CD11b (DuMont et al., 2013a). In addition, puriﬁed LukAB
induce the release of NETs (Malachowa et al., 2013) and
also promotes the escape from the phagosome in neutrophils,
thus enabling S. aureus replication (DuMont et al., 2013b).
Gamma-hemolysin HlgAB andHlgCB bind chemokine receptors
(e.g., CXCR1, CXCR2, and CCR2) and complement receptors
(e.g., C5aR), respectively (Spaan et al., 2014), and promote
the lysis of human neutrophils and macrophages in vitro.
LukED, produced by a large majority of clinical isolates of
S. aureus, triggers the lysis of neutrophils and macrophages
of diﬀerent vertebrates by binding chemokine receptors such
as CCR5, CXCR1 and CXCR2 (Alonzo et al., 2013; Reyes-
Robles et al., 2013). Importantly, LukED was shown to play
a critical role in S. aureus systemic infections in mice, by
promoting bacterial replication in vivo through direct killing
of neutrophils (Alonzo et al., 2012). Lastly, Panton-Valentine
leukocidin (PVL), which is secreted by a small percentage of
S. aureus isolates, binds C5aR on neutrophils and macrophages
and has a restricted activity toward human and rabbit cells
(Spaan et al., 2013a, 2015). Despite the several attempts to
evaluate the exact contribution of each of these toxins to
S. aureus-associated pathologies, their vast species and cell type
speciﬁcities have rendered this analysis highly challenging. In
this context, the data obtained from commonly used animal
infection models (e.g., mice and rats) should be interpreted with
caution.
Mycobacterium ulcerans: SABOTAGE OF
THE HOST IMMUNE RESPONSE BY A
POLYKETIDE TOXIN
Mycobacterium ulcerans is the causative agent of Buruli ulcer,
a chronic ulcerative skin disease that usually starts as painless
nodules on the limbs that then develop into large ulcers.
These can lead to severe scars and local deformities, including
disabling contractures, if not treated at early stages (WHO
Buruli ulcer fact sheet N◦ 199, Updated July 2014). Buruli
ulcer occurs most frequently in children living in tropical
environments, near wetlands. The disease is more common
in poor and rural areas of Africa but is also found in South
America, Asia and Australia.Mycobacterium ulcerans is currently
recognized as an environmental pathogen, but its reservoirs
and mode of transmission remain doubtful (WHO Buruli ulcer
fact sheet N◦ 199, Updated July 2014). Genetically very close
to M. tuberculosis and M. marinum, M. ulcerans is unique
among human pathogenic mycobacteria due to the secretion of
a lipid toxin, the mycolactone (George et al., 1999; Hong et al.,
2008). Mycolactone displays cytotoxic and immunosuppressive
activities and is considered the major pathogenicity factor
in Buruli ulcer, being essential for M. ulcerans virulence,
immune modulation, and colonization (George et al., 1999;
Coutanceau et al., 2005; Marsollier et al., 2005; Torrado et al.,
2007a, 2010; Simmonds et al., 2009; Guenin-Mace et al.,
2011).
In animal models, injection of mycolactone alone is suﬃcient
to cause ulcers similar to those found in infected hosts
(George et al., 1999, 2000). Concerning the mechanism of
cellular intoxication, it has been proposed that, due to its
hydrophobic nature, mycolactone passively diﬀuses through the
plasma membrane (Snyder and Small, 2003; Figure 5). At
micromolar concentrations, mycolactone is highly cytotoxic to
a variety of mammalian cells, with variable susceptibility levels
depending on the cell type (Hall and Simmonds, 2014). The
mycolactone cytotoxicity has been linked to its apoptogenic
activity. Apoptosis was observed in several cell types incubated
in vitro with mycolactone (George et al., 2000; Gama et al.,
2014), when primary mouse macrophages were incubated with
toxigenic M. ulcerans strains (Oliveira et al., 2005), and in
guinea pigs (George et al., 2000) and mice (Oliveira et al., 2005;
Torrado et al., 2007b) infected with mycolactone-producing
M. ulcerans. More importantly, massive apoptosis has been
observed in Buruli ulcer lesions (Walsh et al., 2005). The
mycolactone-induced cell death mechanisms appear to be
complex and are not completely understood. It has been shown
that mycolactone induces cell cycle arrest at the G1/G0-phase
(George et al., 1999), but the connection between this eﬀect
of mycolactone and its cytotoxicity remains unclear. Early
studies on mycolactone reported the occurrence of early actin
cytoskeleton rearrangements, cell rounding, and detachment
following incubation with the toxin (George et al., 1998, 1999).
More recently, studies with HeLa and Jurkat T cells have
shown that mycolactone induces increased actin polymerisation
in intoxicated cells, as a consequence of its binding to the
GTPase domain of the actin-cytoskeleton regulator Wiskott-
Aldrich syndrome protein WASP (Guenin-Mace et al., 2013).
This leads to hyper-activation of WASP and re-localization of
the Arp2/3 complex and consequently, to major cytoskeletal
rearrangements, including the formation of ﬁlopodia (Guenin-
Mace et al., 2013). In epithelial cells, this causes loss of cell
adhesion and E-cadherin-dependent tight junctions, ultimately
leading to the death of detached cells by anoikis (Guenin-
Mace et al., 2013). Recent studies performed in vitro with
murine ﬁbroblasts conﬁrmed the cytoskeleton as a main target
of mycolactone, by showing that mycolactone causes changes
in microtubules and aﬀects several regulators and structural
components of microtubules and microﬁlaments (Gama et al.,
2014). These deleterious eﬀects inﬂicted by mycolactone upon
the cytoskeleton likely contribute to the formation of the
lesions characteristic of Burulli ulcer. Additionally, given the
central role of the cytoskeleton in controlling key cellular
functions, such as endocytosis, intracellular traﬃcking, cell
adhesion and migration, it is reasonable to speculate that,
by highjacking cytoskeleton functions, mycolatone perturbs
the functions of phagocytic cells. Indeed, it is likely that
the decreased phagocytic activity of macrophages exposed to
mycolactone (Adusumilli et al., 2005; Coutanceau et al., 2005)
results from the eﬀect of the toxin upon the cytoskeleton of those
cells. Further investigations are required to determine whether
Frontiers in Microbiology | www.frontiersin.org 13 February 2016 | Volume 7 | Article 42
do Vale et al. Exotoxins Annihilating Macrophages and Neutrophils
FIGURE 5 | Mycolactone inhibits the secretion of most cytokines, chemokines and other inflammatory mediators by macrophages. In eukaryotic cells,
secretory proteins cross the ER membrane before being transported in vesicles to the Golgi complex and then to the plasma membrane. Mycolactone enters cells
by passive diffusion through the plasma membrane and inhibits the production of inflammatory mediators by macrophages by blocking the translocation of nascent
proteins into the ER. The proteins wrongly accumulated in the cytosol are then degraded by the proteasome.
cytoskeleton is manipulated by mycolactone in macrophages and
neutrophils and what are the consequences of this manipulation
in vivo.
In addition to its known cytotoxic eﬀects toward distinct
cell types, at non-cytotoxic concentrations, mycolactone
interferes with important functions of immune cells, including
monocytes, macrophages, and DCs (Arango Duque and
Descoteaux, 2014; Hall and Simmonds, 2014). It is well
recognized that macrophages play crucial roles in mycobacterial
infections, including in Buruli ulcer. Although Buruli ulcer
histopathology is characterized by extensive areas of necrosis
with abundant extracellular bacteria, studies on infected
humans, and experimental M. ulcerans infections revealed that
M. ulcerans is phagocytosed by macrophages and neutrophils,
similarly to the other pathogenic mycobacteria (Torrado
et al., 2007b; Silva et al., 2009) and escape the microbicidal
activity of the macrophages presumably by mycolactone-
dependent interference with the IFNγ–dependent phagosome
maturation and NO production required to control M. ulcerans
infection (Torrado et al., 2010). After an initial phase of
intracellular proliferation, varying according to the strain
cytotoxicity/virulence, M. ulcerans causes apoptosis/necrosis
of the host macrophage through a mycolactone-dependent
mechanism and becomes extracellular (Torrado et al.,
2007b).
Usually, phagocytosis of a microorganism triggers signaling
events that rapidly culminate in a controlled inﬂammatory
response involving the secretion of several cytokines and
chemokines that recruit other inﬂammatory cells to the site of
infection. However, available evidence suggests that this early
response is heavily perturbed by mycolactone. Indeed, cells
exposed to mycolactone-producing strains ofM. ulcerans secrete
much less TNF than those infected with mycolactone-negative
strains (Torrado et al., 2007a) and puriﬁed mycolactone has
been shown to supress the production of several cytokines,
chemokines, and other inﬂammatory mediators by macrophages
(Arango Duque and Descoteaux, 2014; Hall and Simmonds,
2014). It has been proposed that this suppression is associated
with a mycolactone-induced blockade of co-translational protein
translocation into the ER and subsequent degradation of the
aberrantly located proteins in the cytosol (Hall et al., 2014;
Figure 5). Failure to produce cytokines and chemokines may
contribute to the absence of inﬂammatory inﬁltrate at the
central necrotic areas of the lesion containing high numbers
of extracellular bacilli, in addition to the lysis of recruited
inﬂammatory cells induced by the build-up of mycolactone. The
inﬂammatory inﬁltrates occupy a band at the periphery of the
lesion that represents a front that is continuously advancing into
healthy tissues in progressive M. ulcerans lesions (Silva et al.,
2009).
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CONCLUDING REMARKS
The clearance of infectious agents greatly depends on the host
innate immune responses that take place at early stages of
infection and in which macrophages and neutrophils are the
central players. To counteract the host defense mechanisms,
bacterial pathogens secrete a bench of diﬀerent toxins that
neutralize, at diﬀerent levels, the host innate immune response
and in particular, annihilate the function of macrophages and
neutrophils. Despite having diﬀerent features, secreted toxins
targeting the function of innate immune cells often display
similar and/or complementary activities and modulate the same
central pathways of the host cell (e.g., inﬂammatory response,
cytoskeleton dynamics, and cAMP signaling). Furthermore, a
single pathogen may secrete several toxins that act diﬀerently to
produce the same outcome (e.g., inhibit chemotaxis or induce
phagocyte death). These apparently redundant strategies of
bacterial attack ensure the multistep impairment of the early host
immune responses mounted against the pathogen and guarantee
the control of host–pathogen interaction providing a window
of time and opportunity for bacterial growth and establishment
within the host.
In the past, many studies aiming to uncover the molecular
functions of bacterial toxins on host cells were performed in vitro
in several cultured cell lines, and more recently in primary
cells, using a wide range of concentrations of puriﬁed toxins.
In addition, studies on animal models (mainly in rodents)
using either puriﬁed toxins, wild type bacteria and toxin-
deﬁcient mutants, provided a number of important observations
regarding the toxin-mediated pathologies. Together, these studies
generated an incredible amount of data that paradoxically poorly
contributed to the understanding of the role of toxins in
human infections. Whereas in the perspective of using toxins as
molecular tools to address cell biology topics there is great value
in testing toxin eﬀects in many in vitro cell systems, several issues
render extremely diﬃcult the interpretation of data from in vitro
studies in the context of infection. In particular, the concentration
of puriﬁed toxin used is often much higher than that produced by
bacteria during infection and it is highly variable among diﬀerent
studies, and the cell lines tested are often non-relevant for the
pathophysiology of the infection. Regarding studies performed
in animal models, two major concerns have been pointed out:
(1) many toxins display species-speciﬁcity and thus routinely
used models, specially rodents, are non-relevant for the study
of many toxin-mediated human pathologies compromising the
extrapolation of data and (2) direct inoculation of puriﬁed toxins
in the animals only provide limited information that do not
necessarily recapitulate the eﬀect of a given toxin in the context
of human bacterial infection. Thus, the data generated so far
needs to be cautiously analyzed whenever we aim to better
understand the role of toxins in the in vivo infectious process.
The accurate role of toxins in human infections needs to be
analyzed in the context of bacterial infections in diﬀerent animal
species. In this perspective, future eﬀorts should concentrate in
the development and use of appropriate animal models, possibly
non-human primates, in which available in vitro and in vivo
data can be conﬁrmed and possibly extrapolated to the human
pathologies.
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